The latest issue of Financial Standard now available as an e-newspaper
HESTA injects $4.4m into Aussie biotech startupBY CHLOE WALKER | WEDNESDAY, 1 JUN 2022 12:46PM
Sydney-based Inventia Life Science has announced the super fund's direct investment as it develops, manufactures and distributes the RASTRUM 3D bioprinter.
Read more: HESTA, Inventia Life Science, Julio Ribeiro, Sonya Sawtell-Rickson, Aidan Mahony
Upgrade your subscription to access this article
And gain access to:
Insignia Financial has responded to media speculation that it's in discussions with Equity Trustees (EQT) over the sale of its Australian Executor Trustees (AET) business.
As it looks to increase its exposure to US markets, AustralianSuper has made a raft of appointments to its New York based investment team and relocated its head of private equity.
Long-anticipated superannuation laws that allow de facto couples to split their super assets in the event of a relationship breakdown have finally passed in Western Australia.
NGS Super has made two new hires to strengthen its capabilities in international and Australian equities, as the fund works toward a carbon-neutral investment portfolio by 2030.
Vanguard, the ETF giant, has presented an odd submission to the Quality of Advice Review.
With the RBA tightening cycle firmly underway, the impact for Australian households is only starting to be felt.
There's no doubt the superannuation system, which turned 30 this year, has been a game changer.
We've all probably been there. The days when we used to ask beginner, dumb, naïve questions about why things are done a certain way, starry-eyed questions ...
Do you think greenwashing is a serious issue in the Australian funds management sector?
GROUP EXECUTIVE OF MEMBERSHIP AND BRAND
Driven by a relentless commitment to helping others, it's of little wonder Rose Kerlin has excelled at leading profit to member and purpose-led organisations. Andrew McKean writes.